TG Therapeutics: What Wall Street Isn't Telling You
Source: SeekingAlpha
2025-12-30 11:00:55 ET
TG Therapeutics, Inc. ( TGTX ) is becoming a prominent player in the multiple sclerosis therapeutics market thanks to its Briumvi [ ublituximab ], an anti-CD20 monoclonal antibody....
Read the full article on Seeking Alpha
For further details see:
TG Therapeutics: What Wall Street Isn't Telling You
Novartis AG
NASDAQ: NVS
NVS Trading
0.06% G/L:
$143.45 Last:
314,832 Volume:
$142.47 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
